Paul S. Jones

2.0k total citations
44 papers, 1.2k citations indexed

About

Paul S. Jones is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Paul S. Jones has authored 44 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Organic Chemistry. Recurrent topics in Paul S. Jones's work include Hepatitis C virus research (7 papers), HIV/AIDS drug development and treatment (5 papers) and Skin and Cellular Biology Research (3 papers). Paul S. Jones is often cited by papers focused on Hepatitis C virus research (7 papers), HIV/AIDS drug development and treatment (5 papers) and Skin and Cellular Biology Research (3 papers). Paul S. Jones collaborates with scholars based in United Kingdom, United States and Australia. Paul S. Jones's co-authors include Nisson Schechter, Ian N.H. White, Wolfgang Quitschke, David Jones, David Bell, Tim J.B. Gray, Jacqui Shaw, Robert J. Jones, Patricia S. Steeg and JEFF EVANS and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Molecular and Cellular Biology.

In The Last Decade

Paul S. Jones

44 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul S. Jones United Kingdom 20 611 230 159 158 141 44 1.2k
Jeong‐Min Kim South Korea 25 850 1.4× 219 1.0× 223 1.4× 180 1.1× 98 0.7× 51 1.4k
Yoshihiko Noguchi Japan 20 732 1.2× 246 1.1× 141 0.9× 151 1.0× 94 0.7× 61 1.4k
Mariko Shimamura Japan 24 826 1.4× 353 1.5× 251 1.6× 143 0.9× 96 0.7× 58 1.5k
Yongmun Choi South Korea 15 1.3k 2.1× 226 1.0× 106 0.7× 133 0.8× 150 1.1× 34 1.7k
John P. Alao Sweden 18 1.0k 1.7× 435 1.9× 227 1.4× 176 1.1× 104 0.7× 33 1.6k
George W. Small United States 19 1.1k 1.8× 338 1.5× 141 0.9× 88 0.6× 109 0.8× 32 1.7k
Ronald L. Merriman United States 17 767 1.3× 224 1.0× 118 0.7× 186 1.2× 88 0.6× 35 1.2k
Uttam Pati India 23 641 1.0× 251 1.1× 229 1.4× 96 0.6× 74 0.5× 40 1.1k
Rana Anjum India 12 1.0k 1.7× 179 0.8× 98 0.6× 93 0.6× 195 1.4× 20 1.4k
A‐Mei Huang Taiwan 23 735 1.2× 232 1.0× 194 1.2× 91 0.6× 80 0.6× 51 1.2k

Countries citing papers authored by Paul S. Jones

Since Specialization
Citations

This map shows the geographic impact of Paul S. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul S. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul S. Jones more than expected).

Fields of papers citing papers by Paul S. Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul S. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul S. Jones. The network helps show where Paul S. Jones may publish in the future.

Co-authorship network of co-authors of Paul S. Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Paul S. Jones. A scholar is included among the top collaborators of Paul S. Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul S. Jones. Paul S. Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jones, Paul S., et al.. (2021). Assessment of the Educational Value of Distal Hypospadias Repair Videos on YouTube. Urology. 159. 28–32. 3 indexed citations
3.
Kumar, Rajiv, Dionysis Papadatos-Pastos, Joaquı́n Mateo, et al.. (2020). First-in-Human Study of AT13148, a Dual ROCK-AKT Inhibitor in Patients with Solid Tumors. Clinical Cancer Research. 26(18). 4777–4784. 52 indexed citations
4.
Bax, Heather J., Jitesh Chauhan, Chara Stavraka, et al.. (2020). Basophils from Cancer Patients Respond to Immune Stimuli and Predict Clinical Outcome. Cells. 9(7). 1631–1631. 31 indexed citations
5.
Plummer, Ruth, Sarah Halford, Paul S. Jones, et al.. (2018). A first-in-human first-in-class (FIC) trial of the monocarboxylate transporter 1 (MCT1) inhibitor AZD3965 in patients with advanced solid tumours. Annals of Oncology. 29. iii9–iii9. 24 indexed citations
6.
Saul, Louise, Louise Saul, Debra H. Josephs, et al.. (2014). Comparative reactivity of human IgE to cynomolgus monkey and human effector cells and effects on IgE effector cell potency. mAbs. 6(2). 509–522. 12 indexed citations
7.
Jones, Paul S. & David Jones. (2011). New regulatory framework for cancer drug development. Drug Discovery Today. 17(5-6). 227–231. 14 indexed citations
8.
Mitchell, Charlotte, Stuart P. Ballantine, Diane M. Coe, et al.. (2010). Pyrazolopyridines as potent PDE4B inhibitors: 5-Heterocycle SAR. Bioorganic & Medicinal Chemistry Letters. 20(19). 5803–5806. 34 indexed citations
9.
Keenan, Emma, et al.. (2010). How much theanine in a cup of tea? Effects of tea type and method of preparation. Food Chemistry. 125(2). 588–594. 52 indexed citations
10.
Hamblin, J., Stuart P. Ballantine, Anthony W. J. Cooper, et al.. (2008). Pyrazolopyridines as a novel structural class of potent and selective PDE4 inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(14). 4237–4241. 59 indexed citations
11.
Gross, Matthew, Roland W. Bürli, Paul S. Jones, et al.. (2003). Pharmacology of Novel Heteroaromatic Polycycle Antibacterials. Antimicrobial Agents and Chemotherapy. 47(11). 3448–3457. 13 indexed citations
12.
Andrews, David, Martin R. Johnson, Paul S. Jones, et al.. (2003). The design of potent, non-peptidic inhibitors of hepatitis C protease. European Journal of Medicinal Chemistry. 38(4). 339–343. 12 indexed citations
13.
Dean, Diane M., Paul S. Jones, & Michel M. Sanders. (2001). Alterations in Chromatin Structure Are Implicated in the Activation of the Steroid Hormone Response Unit of the Ovalbumin Gene. DNA and Cell Biology. 20(1). 27–39. 9 indexed citations
14.
Jones, Paul S., Paul W. Smith, George W. Hardy, et al.. (1999). Synthesis of tetrasubstituted bicyclo[3.2.1]octenes as potential inhibitors of influenza virus sialidase. Bioorganic & Medicinal Chemistry Letters. 9(4). 605–610. 8 indexed citations
15.
Andrews, David, et al.. (1999). Synthesis and influenza virus sialidase inhibitory activity of analogues of 4-Guanidino-Neu5Ac2en (Zanamivir) modified in the glycerol side-chain. European Journal of Medicinal Chemistry. 34(7-8). 563–574. 33 indexed citations
16.
Dean, Diane M., Paul S. Jones, & Michel M. Sanders. (1996). Regulation of the Chicken Ovalbumin Gene by Estrogen and Corticosterone Requires a Novel DNA Element That Binds a Labile Protein, Chirp-I. Molecular and Cellular Biology. 16(5). 2015–2024. 15 indexed citations
17.
Scanlon, Denis B., et al.. (1994). Synthesis of cyclic penta- and hexapeptides: A general synthetic strategy on DAS resin. Journal of Protein Chemistry. 13(3). 339–346. 2 indexed citations
18.
19.
Levine, Edward M., et al.. (1992). Cloning of a type I keratin from goldfish optic nerve: differential expression of keratins during regeneration. Differentiation. 52(1). 33–43. 19 indexed citations
20.
Jones, Paul S. & Nisson Schechter. (1987). Distribution of specific intermediate‐filament proteins in the goldfish retina. The Journal of Comparative Neurology. 266(1). 112–121. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeong‐Min Kim Breakdown of academic impact, for papers by Yoshihiko Noguchi Breakdown of academic impact, for papers by Mariko Shimamura Breakdown of academic impact, for papers by Yongmun Choi Breakdown of academic impact, for papers by John P. Alao Breakdown of academic impact, for papers by George W. Small Breakdown of academic impact, for papers by Ronald L. Merriman Breakdown of academic impact, for papers by Uttam Pati Breakdown of academic impact, for papers by Rana Anjum Breakdown of academic impact, for papers by A‐Mei Huang
Rankless by CCL
2026